Last reviewed · How we verify
ILB2109
At a glance
| Generic name | ILB2109 |
|---|---|
| Sponsor | Innolake Biopharm |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of ILB2109 in Patients With Advanced Solid Malignancies (PHASE1)
- A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |